person · Reporting owner

Bourque Michael J.

Disclosed activity across 3 companies

Tapewire entity: 63228
SEC CIK: 0001638420

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Inogen IncINGN · Entity 2083	EVP, CFO & Treasurer	February 27, 2026	March 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Inogen Inc

Report date February 27, 2026 · Filed March 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	94,596	Ending reported balance After 2026-03-01 transaction · row 7 7 source rows · reconciled sequence Row 1 · 2026-03-01 · Grant · Acquired 874 · Balance 50,020 F1: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. Row 2 · 2026-03-01 · Exercise / conversion · Acquired 25,000 · Balance 75,020 Row 3 · 2026-03-01 · Tax withholding · Disposed 9,338 · Balance 65,682 F2: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. Row 4 · 2026-03-01 · Grant · Acquired 28,875 · Balance 94,557 F3: The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024. Row 5 · 2026-03-01 · Tax withholding · Disposed 10,615 · Balance 83,942 F4: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026. Row 6 · 2026-03-01 · Exercise / conversion · Acquired 17,007 · Balance 100,949 Row 7 · 2026-03-01 · Tax withholding · Disposed 6,353 · Balance 94,596 F2: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	39,000	Reported balance After 2026-02-27 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2026-02-27 · Grant · Acquired 39,000 · Balance 39,000 F5: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	25,000	Reported balance After 2026-03-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2026-03-01 · Exercise / conversion · Disposed 25,000 · Balance 25,000 F5: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	34,013	Reported balance After 2026-03-01 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2026-03-01 · Exercise / conversion · Disposed 17,007 · Balance 34,013 F5: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F8: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

Filing footnotes · ownership attribution and instrument terms

F1: Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

F2: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.

F3: The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024.

F4: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026.

F5: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F6: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.

F7: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.

F8: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ANALOGIC CORP

Report date June 22, 2018 · Filed June 26, 2018

Section 16 reporting ended · disclosed 2018-06-26. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2018-06-22 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2018-06-22 · Exercise / conversion · Acquired 3,387 · Balance 4,377 F2: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. Row 2 · 2018-06-22 · Exercise / conversion · Acquired 5,336 · Balance 9,713 F3: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. Row 3 · 2018-06-22 · Disposition to issuer · Disposed 9,713 · Balance 0 F1: On June 22, 2018, pursuant to the Agreement and Plan of Merger, by and among the issuer, AC Merger Sub, Inc. ("Merger Sub") and ANLG Holding Company, Inc. ("Parent"), dated April 10, 2018 (the "Merger Agreement"), Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, the shares of Common Stock automatically converted into the right to receive $84.00 per share in cash (the "Merger Consideration").
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-06-22 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-06-22 · Exercise / conversion · Disposed 3,387 · Balance 0 F2: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-06-22 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-06-22 · Exercise / conversion · Disposed 5,336 · Balance 0 F3: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.

Filing footnotes · ownership attribution and instrument terms

F1: On June 22, 2018, pursuant to the Agreement and Plan of Merger, by and among the issuer, AC Merger Sub, Inc. ("Merger Sub") and ANLG Holding Company, Inc. ("Parent"), dated April 10, 2018 (the "Merger Agreement"), Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, the shares of Common Stock automatically converted into the right to receive $84.00 per share in cash (the "Merger Consideration").

F2: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.

F3: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share.

CHASE CORP

Report date November 15, 2023 · Filed November 15, 2023

Section 16 reporting ended · disclosed 2023-11-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Chase Corporation Common StockSEC Table I · non-derivative	Direct	Reported balance After 2023-11-15 transaction · row 1 1 source row Row 1 · 2023-11-15 · Disposition to issuer · Disposed 9,738 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger, dated as of July 21, 2023, by and among Chase Corporation (the "Issuer"), Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, effective as of November 15, 2023 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each issued and outstanding share of the Issuer's Common Stock (each, a "Share") was cancelled and, except in the case of certain unvested Shares that were forfeited as of the Effective Time or as otherwise agreed between Parent and the holder thereof, was converted into the right to receive $127.50 in cash (the "Per Share Consideration"), subject to any applicable withholding of taxes and without interest.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $104.04 · Expires 2030-09-01	Direct	Reported balance After 2023-11-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-11-15 · Disposition to issuer · Disposed 749 · Balance 0 F2: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $114.50 · Expires 2031-09-01	Direct	Reported balance After 2023-11-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-11-15 · Disposition to issuer · Disposed 1,163 · Balance 0 F2: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $94.88 · Expires 2032-02-01	Direct	Reported balance After 2023-11-15 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-11-15 · Disposition to issuer · Disposed 14,480 · Balance 0 F2: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $88.16 · Expires 2032-09-01	Direct	Reported balance After 2023-11-15 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2023-11-15 · Disposition to issuer · Disposed 1,520 · Balance 0 F2: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger, dated as of July 21, 2023, by and among Chase Corporation (the "Issuer"), Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, effective as of November 15, 2023 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each issued and outstanding share of the Issuer's Common Stock (each, a "Share") was cancelled and, except in the case of certain unvested Shares that were forfeited as of the Effective Time or as otherwise agreed between Parent and the holder thereof, was converted into the right to receive $127.50 in cash (the "Per Share Consideration"), subject to any applicable withholding of taxes and without interest.

F2: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	Exercise / conversionRestricted Stock Unit · Derivative	17,007	$0.00	$0.00	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · derivative · entry 10 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,013 Underlying: Common Stock · 17,007 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F8 · derivative.exercise_date: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date. F8 · derivative.expiration_date: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	Exercise / conversionRestricted Stock Unit · Derivative	25,000	$0.00	$0.00	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · derivative · entry 9 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. F7 · derivative.expiration_date: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	Tax withholdingCommon Stock	6,353	$6.10	$38,753.30	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · nonDerivative · entry 7 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,596 F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	Exercise / conversionCommon Stock	17,007	$0.00	$0.00	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · nonDerivative · entry 6 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	Tax withholdingCommon Stock	10,615	$6.10	$64,751.50	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · nonDerivative · entry 5 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,942 F4 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	GrantCommon Stock	28,875	$0.00	$0.00	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · nonDerivative · entry 4 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,557 F3 · shares: The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	Tax withholdingCommon Stock	9,338	$6.10	$56,961.80	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · nonDerivative · entry 3 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,682 F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	Exercise / conversionCommon Stock	25,000	$0.00	$0.00	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · nonDerivative · entry 2 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	GrantCommon Stock	874	$6.10	$5,331.40	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,020 F1 · shares: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:57 UTC	Inogen Inc INGN · Entity 2083	GrantRestricted Stock Unit · Derivative	39,000	$0.00	$0.00	Disclosure SEC source: 0001193125-26-088586 · ownership.xml · derivative · entry 8 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 39,000 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. Read SEC document
September 01, 2025 Filed Sep 3, 2025 21:03 UTC	Inogen Inc INGN · Entity 2083	GrantCommon Stock	1,500	$7.99	$11,985.00	Disclosure SEC source: 0001638420-25-000004 · ownership.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,146 F1 · shares: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. Read SEC document
March 03, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	PurchaseCommon Stock	3,000	$8.32	$24,960.00	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · nonDerivative · entry 6 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,646 Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	Exercise / conversionRestricted Stock Unit · Derivative	25,000	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · derivative · entry 8 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. F7 · derivative.expiration_date: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	Tax withholdingCommon Stock	18,741	$8.33	$156,112.53	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · nonDerivative · entry 5 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,646 F4 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2025. Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	GrantCommon Stock	47,625	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · nonDerivative · entry 4 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,387 F3 · shares: The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024. Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	Tax withholdingCommon Stock	9,838	$8.33	$81,950.54	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · nonDerivative · entry 3 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,762 F2 · shares: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025. Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	Exercise / conversionCommon Stock	25,000	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · nonDerivative · entry 2 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	GrantCommon Stock	600	$8.33	$4,998.00	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 600 F1 · shares: Shares acquired through the Company's 2014 Employee Stock Purchase Plan. Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:42 UTC	Inogen Inc INGN · Entity 2083	GrantRestricted Stock Unit · Derivative	51,020	$0.00	$0.00	Disclosure SEC source: 0000950170-25-032642 · ownership.xml · derivative · entry 7 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,020 Underlying: Common Stock · 51,020 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document
March 04, 2024 Filed Mar 7, 2024 01:46 UTC	Inogen Inc INGN · Entity 2083	GrantRestricted Stock Unit · Derivative	75,000	$0.00	$0.00	Disclosure SEC source: 0000950170-24-027519 · ownership.xml · derivative · entry 1 Bourque Michael J. · CIK 0001638420 · EVP, CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2024 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document
November 15, 2023 Filed Nov 15, 2023 19:25 UTC	CHASE CORP CCF · Entity 108274	Disposition to issuerStock Options · Derivative	1,520	Not disclosed Strike: $88.16	Not disclosed	Disclosure SEC source: 0000950103-23-016306 · dp202781_4-bourque.xml · derivative · entry 5 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,520 shares Expires 2032-09-01 F2 · price: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. F2 · derivative.exercise_date: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. Read SEC document
November 15, 2023 Filed Nov 15, 2023 19:25 UTC	CHASE CORP CCF · Entity 108274	Disposition to issuerStock Options · Derivative	14,480	Not disclosed Strike: $94.88	Not disclosed	Disclosure SEC source: 0000950103-23-016306 · dp202781_4-bourque.xml · derivative · entry 4 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,480 shares Expires 2032-02-01 F2 · price: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. F2 · derivative.exercise_date: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. Read SEC document
November 15, 2023 Filed Nov 15, 2023 19:25 UTC	CHASE CORP CCF · Entity 108274	Disposition to issuerStock Options · Derivative	1,163	Not disclosed Strike: $114.50	Not disclosed	Disclosure SEC source: 0000950103-23-016306 · dp202781_4-bourque.xml · derivative · entry 3 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,163 shares Expires 2031-09-01 F2 · price: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. F2 · derivative.exercise_date: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. Read SEC document
November 15, 2023 Filed Nov 15, 2023 19:25 UTC	CHASE CORP CCF · Entity 108274	Disposition to issuerStock Options · Derivative	749	Not disclosed Strike: $104.04	Not disclosed	Disclosure SEC source: 0000950103-23-016306 · dp202781_4-bourque.xml · derivative · entry 2 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 749 shares Expires 2030-09-01 F2 · price: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. F2 · derivative.exercise_date: Represents options to purchase Shares (each, an "Option") held by the Reporting Person. In accordance with the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, became fully vested and was automatically canceled and converted into the right to receive a cash payment, without interest, in an amount equal to the product of (i) the excess, if any, of the Per Share Consideration over the applicable per share exercise price of such Option, multiplied by (ii) the number of shares of Shares issuable in respect of such Option as of immediately prior to the Effective Time, subject to any applicable withholding of taxes. Read SEC document
November 15, 2023 Filed Nov 15, 2023 19:25 UTC	CHASE CORP CCF · Entity 108274	Disposition to issuerChase Corporation Common Stock	9,738	Not disclosed	Not disclosed	Disclosure SEC source: 0000950103-23-016306 · dp202781_4-bourque.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger, dated as of July 21, 2023, by and among Chase Corporation (the "Issuer"), Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, effective as of November 15, 2023 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each issued and outstanding share of the Issuer's Common Stock (each, a "Share") was cancelled and, except in the case of certain unvested Shares that were forfeited as of the Effective Time or as otherwise agreed between Parent and the holder thereof, was converted into the right to receive $127.50 in cash (the "Per Share Consideration"), subject to any applicable withholding of taxes and without interest. Read SEC document
October 13, 2023 Filed Oct 17, 2023 16:47 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	150	$0.00	$0.00	Disclosure SEC source: 0001415889-23-014349 · form4-10172023_081050.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,738 F1 · shares: Represents restricted stock vesting on August 31, 2025. Read SEC document
September 01, 2023 Filed Sep 5, 2023 21:52 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	1,750	$0.00	$0.00	Disclosure SEC source: 0001415889-23-012927 · form4-09062023_010907.xml · nonDerivative · entry 2 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,588 F2 · shares: Represents restricted stock vesting on August 31, 2026. Read SEC document
August 31, 2023 Filed Sep 5, 2023 21:52 UTC	CHASE CORP CCF · Entity 108274	Tax withholdingChase Corporation Common Stock	288	$126.50	$36,432.00	Disclosure SEC source: 0001415889-23-012927 · form4-09062023_010907.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,838 F1 · shares: This amount represents shares withheld to pay minimum statutory income taxes pursuant to the vesting of restricted stock previously reported. The restricted stock vested on August 31, 2023. Read SEC document
November 10, 2022 Filed Nov 14, 2022 14:57 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	617	$0.00	$0.00	Disclosure SEC source: 0001415889-22-011332 · form4-11142022_071110.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,126 F1 · shares: Represents restricted stock vesting on August 31, 2024. Read SEC document
September 01, 2022 Filed Sep 6, 2022 16:50 UTC	CHASE CORP CCF · Entity 108274	GrantOptions (Right to Buy) · Derivative	1,520	$0.00 Strike: $88.16	$0.00	Disclosure SEC source: 0001415889-22-009400 · form4-09062022_010912.xml · derivative · entry 2 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520 Underlying: Common Stock · 1,520 shares Expires 2032-09-01 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on August 31, 2023. Read SEC document
September 01, 2022 Filed Sep 6, 2022 16:50 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	580	$0.00	$0.00	Disclosure SEC source: 0001415889-22-009400 · form4-09062022_010912.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,509 F1 · shares: Represents restricted stock vesting on August 31, 2025. Read SEC document
February 01, 2022 Filed Feb 3, 2022 14:38 UTC	CHASE CORP CCF · Entity 108274	GrantOptions (Right to Buy) · Derivative	14,480	$0.00 Strike: $94.88	$0.00	Disclosure SEC source: 0001415889-22-001022 · form4-02032022_110212.xml · derivative · entry 2 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,480 Underlying: Common Stock · 14,480 shares Expires 2032-02-01 F2 · shares: Stock options cliff vest after three years on January 31, 2025. Read SEC document
February 01, 2022 Filed Feb 3, 2022 14:38 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	5,332	$0.00	$0.00	Disclosure SEC source: 0001415889-22-001022 · form4-02032022_110212.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · TREASURER & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,929 F1 · shares: Represents restricted stock vesting on January 31, 2025. Read SEC document
September 29, 2021 Filed Nov 29, 2021 13:42 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	922	$0.00	$0.00	Disclosure SEC source: 0001179110-21-010432 · edgar.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,597 F1 · shares: Represents restricted stock vesting on August 31, 2023. Read SEC document
September 01, 2021 Filed Sep 2, 2021 14:38 UTC	CHASE CORP CCF · Entity 108274	GrantOptions (Right to Buy) · Derivative	1,163	$0.00 Strike: $114.50	$0.00	Disclosure SEC source: 0001179110-21-008524 · edgar.xml · derivative · entry 2 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,163 Underlying: Common Stock · 1,163 shares Expires 2031-09-01 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on August 31, 2022. Read SEC document
September 01, 2021 Filed Sep 2, 2021 14:38 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	414	$0.00	$0.00	Disclosure SEC source: 0001179110-21-008524 · edgar.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675 F1 · shares: Represents restricted stock vesting on August 31, 2024. Read SEC document
February 02, 2021 Filed Feb 4, 2021 18:56 UTC	CHASE CORP CCF · Entity 108274	GrantOptions (Right to Buy) · Derivative	749	$0.00 Strike: $104.04	$0.00	Disclosure SEC source: 0001179110-21-001325 · edgar.xml · derivative · entry 2 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749 Underlying: Common Stock · 749 shares Expires 2030-08-31 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on August 31, 2021. Read SEC document
February 02, 2021 Filed Feb 4, 2021 18:56 UTC	CHASE CORP CCF · Entity 108274	GrantChase Corporation Common Stock	261	$0.00	$0.00	Disclosure SEC source: 0001179110-21-001325 · edgar.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · Treasurer & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261 F1 · shares: Represents restricted stock vesting on August 31, 2023. Read SEC document
June 22, 2018 Filed Jun 26, 2018 14:01 UTC	ANALOGIC CORP ALOG · Entity 165469	Exercise / conversionRestricted Stock Units · Derivative	5,336	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-018080 · doc4.xml · derivative · entry 5 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. F3 · price: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. F3 · derivative.exercise_date: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. F3 · derivative.expiration_date: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. Read SEC document
June 22, 2018 Filed Jun 26, 2018 14:01 UTC	ANALOGIC CORP ALOG · Entity 165469	Exercise / conversionRestricted Stock Units · Derivative	3,387	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-018080 · doc4.xml · derivative · entry 4 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. F2 · price: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. F2 · derivative.exercise_date: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. F2 · derivative.expiration_date: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. Read SEC document
June 22, 2018 Filed Jun 26, 2018 14:01 UTC	ANALOGIC CORP ALOG · Entity 165469	Disposition to issuerCommon Stock	9,713	$84.00	$815,892.00	Disclosure SEC source: 0000899243-18-018080 · doc4.xml · nonDerivative · entry 3 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On June 22, 2018, pursuant to the Agreement and Plan of Merger, by and among the issuer, AC Merger Sub, Inc. ("Merger Sub") and ANLG Holding Company, Inc. ("Parent"), dated April 10, 2018 (the "Merger Agreement"), Merger Sub merged with and into the issuer (the "Merger"), with the issuer surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, the shares of Common Stock automatically converted into the right to receive $84.00 per share in cash (the "Merger Consideration"). Read SEC document
June 22, 2018 Filed Jun 26, 2018 14:01 UTC	ANALOGIC CORP ALOG · Entity 165469	Exercise / conversionCommon Stock	5,336	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-018080 · doc4.xml · nonDerivative · entry 2 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Represents unvested performance-based share unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested performance-based restricted share unit as of immediately prior to the Effective Time vested with respect to the number of shares of Common Stock that would have been earned in accordance with the methodology set forth in the applicable award agreement or previously established by the Compensation Committee of the issuer's Board of Directors and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. Read SEC document
June 22, 2018 Filed Jun 26, 2018 14:01 UTC	ANALOGIC CORP ALOG · Entity 165469	Exercise / conversionCommon Stock	3,387	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-18-018080 · doc4.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Represents unvested time-based restricted stock unit awards that became vested and were converted in the Merger into the right to receive the Merger Consideration. Pursuant to the terms of the Merger Agreement, each outstanding and unvested time-based restricted share unit as of immediately prior to the Effective Time vested in full and was automatically canceled and converted into the right to receive the Merger Consideration for each underlying share. Read SEC document
December 04, 2017 Filed Dec 4, 2017 19:13 UTC	ANALOGIC CORP ALOG · Entity 165469	Exercise / conversionRestricted Stock Units · Derivative	225	$0.00	$0.00	Disclosure SEC source: 0000899243-17-027914 · doc4.xml · derivative · entry 3 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the vesting of time-based RSU's granted on 12/4/2014. F1 · derivative.exercise_date: Represents the vesting of time-based RSU's granted on 12/4/2014. F1 · derivative.expiration_date: Represents the vesting of time-based RSU's granted on 12/4/2014. Read SEC document
December 04, 2017 Filed Dec 4, 2017 19:13 UTC	ANALOGIC CORP ALOG · Entity 165469	Tax withholdingCommon Stock	74	$81.60	$6,038.40	Disclosure SEC source: 0000899243-17-027914 · doc4.xml · nonDerivative · entry 2 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 Read SEC document
December 04, 2017 Filed Dec 4, 2017 19:13 UTC	ANALOGIC CORP ALOG · Entity 165469	Exercise / conversionCommon Stock	225	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-17-027914 · doc4.xml · nonDerivative · entry 1 Bourque Michael J. · CIK 0001638420 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the vesting of time-based RSU's granted on 12/4/2014. Read SEC document
September 14, 2017 Filed Sep 18, 2017 19:13 UTC	ANALOGIC CORP ALOG · Entity 165469	Exercise / conversionRestricted Stock Units · Derivative	237	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-17-022252 · doc4.xml · derivative · entry 5 Bourque Michael J. · CIK 0001638420 · Sr. VP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents the vesting of performance-based award granted on 9/8/14. F3 · price: Represents the vesting of performance-based award granted on 9/8/14. F3 · derivative.exercise_date: Represents the vesting of performance-based award granted on 9/8/14. F3 · derivative.expiration_date: Represents the vesting of performance-based award granted on 9/8/14. Read SEC document
September 14, 2017 Filed Sep 18, 2017 19:13 UTC	ANALOGIC CORP ALOG · Entity 165469	GrantRestricted Stock Units · Derivative	2,243	$0.00	$0.00	Disclosure SEC source: 0000899243-17-022252 · doc4.xml · derivative · entry 4 Bourque Michael J. · CIK 0001638420 · Sr. VP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,243 Underlying: Common Stock · 2,243 shares Expires not disclosed F2 · derivative.exercise_price: The time-based RSUs will cliff vest on July 31, 2020. On that date, the RSUs will be converted to common stock and a like number of shares will be issued to the grantee. F2 · derivative.exercise_date: The time-based RSUs will cliff vest on July 31, 2020. On that date, the RSUs will be converted to common stock and a like number of shares will be issued to the grantee. F2 · derivative.expiration_date: The time-based RSUs will cliff vest on July 31, 2020. On that date, the RSUs will be converted to common stock and a like number of shares will be issued to the grantee. Read SEC document
September 14, 2017 Filed Sep 18, 2017 19:13 UTC	ANALOGIC CORP ALOG · Entity 165469	GrantRestricted Stock Units · Derivative	4,505	$0.00	$0.00	Disclosure SEC source: 0000899243-17-022252 · doc4.xml · derivative · entry 3 Bourque Michael J. · CIK 0001638420 · Sr. VP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,505 Underlying: Common Stock · 4,505 shares Expires not disclosed F1 · derivative.exercise_price: The number of Restricted Stock Units ("RSUs)" represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded will vary depending on the Company's performance. The performance period will end on July 31, 2020. Thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee. F1 · derivative.exercise_date: The number of Restricted Stock Units ("RSUs)" represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded will vary depending on the Company's performance. The performance period will end on July 31, 2020. Thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee. F1 · derivative.expiration_date: The number of Restricted Stock Units ("RSUs)" represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded will vary depending on the Company's performance. The performance period will end on July 31, 2020. Thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee. Read SEC document
September 14, 2017 Filed Sep 18, 2017 19:13 UTC	ANALOGIC CORP ALOG · Entity 165469	Tax withholdingCommon Stock	78	$77.15	$6,017.70	Disclosure SEC source: 0000899243-17-022252 · doc4.xml · nonDerivative · entry 2 Bourque Michael J. · CIK 0001638420 · Sr. VP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 839 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.